← Open Payments lookup

KINGSLEY OYEM: Open Payments

NPI 1477062347 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,076 in 56 payments from 9 companies in 2025. Trend: 2023 $1,394 · 2024 $1,317 · 2025 $1,076

Food & beverage: $1,076
CompanyPaymentsAmount
ABBVIE INC.31$422
E.R. Squibb & Sons, L.L.C.8$341
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$84
Vanda Pharmaceuticals Inc.4$71
Otsuka America Pharmaceutical, Inc.4$64
Lundbeck LLC2$38
Teva Pharmaceuticals USA, Inc.1$21
Neurocrine BioSciences, Inc.1$20
Supernus Pharmaceuticals, Inc.1$15

Products named: VRAYLAR, COBENFY, REXULTI, CAPLYTA, FANAPT, UZEDY, INGREZZA, Qelbree.

Industry payments across NJ — which companies pay providers there.